Clinical Trials - Phase I
Filter News
Found 21,039 articles
-
Curetis Initiates Next Phase Of Unyvero U.S. FDA Trial In Lower Respiratory Tract Infections
7/8/2015
-
Arrowhead Research Corporation Receives Regulatory Clearance For ARC-AAT Phase 1 In The United Kingdom And New Zealand
7/8/2015
-
FDA Bestows Breakthrough Therapy Designation on Dyax Corp.'s HAE Drug As Suitors Circle
7/7/2015
-
CureVac Announces Phase I/IIa Clinical Study Data Of Its mRNA Cancer Immunotherapy In Prostate Cancer Published In The Journal For Immunotherapy Of Cancer
7/7/2015
-
Abide Therapeutics Announces First Subject Dosed In First-In-Human Clinical Study Of ABX-1431, An Investigational Endocannabinoid System Modulator
7/7/2015
-
Enzymotec Announces Investigator Initiated Clinical Trial Of Vayarin In Managing ADHD In Children With Epilepsy
7/7/2015
-
Dyax Corp. Receives FDA Breakthrough Therapy Designation For DX-2930 For Prevention Of Attacks Of Hereditary Angioedema
7/7/2015
-
Blaze Bioscience Inc.’s BLZ-100 Receives Orphan Drug Designation From FDA For Brain Cancer
7/7/2015
-
WCCT Global Completes Multiple Ethnobridging Studies At Phase I CPUs
7/7/2015
-
Catabasis Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy
7/6/2015
-
PhytoTech Medical Ltd (ASX:PYL) Oral Formulations Advance Towards Phase 1 Clinical Trials
7/6/2015
-
XBiotech USA Treats First Patient In Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus
7/6/2015
-
Avexxin Completes Phase I/IIA Study In Psoriasis And Achieves Proof-Of-Concept In Man With Its Compound AVX001 In A Topical Formulation
7/2/2015
-
Provectus Biopharmaceuticals Inc.’ Data On PV-10 For Chemoablation Of Liver Cancers Presented At ESMO 17th World Congress On Gastrointestinal Cancer
7/2/2015
-
Immunovaccine Inc. Publishes Clinical Results With DPX-Survivac In Combination With An Immune-Modulating Compound
7/2/2015
-
EXCLUSIVE: Pediatric Patients Could Benefit Most From New Oncoceutics Cancer Drug, Says Exec
7/2/2015
-
Arrowhead Research Corporation Initiates Dosing Of ARC-AAT In Patients With Alpha-1 Antitrypsin Deficiency
7/2/2015
-
Vitae Pharma’ Diabetes Drug Fails Mid-Stage Trial, the Second Drug in Less Than Six Months to Fail
7/1/2015
-
Intralink-Spine Announces Long-Term Large-Animal Testing Shows Positive Results Related To Lower Back Pain
7/1/2015
-
Rock Creek Pharmaceuticals Reports Human Proof Of Principle Study Of Lead Compound Demonstrating Inhibition Of Inflammatory Markers In White Blood Cells
7/1/2015